These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1846178)

  • 1. Phosphorylation by cyclic AMP-dependent protein kinase modulates agonist binding to the D2 dopamine receptor.
    Elazar Z; Fuchs S
    J Neurochem; 1991 Jan; 56(1):75-80. PubMed ID: 1846178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanadate inhibits agonist binding to D2 dopamine receptor.
    Elazar Z; Fuchs S
    J Mol Neurosci; 1991; 3(1):1-6. PubMed ID: 1679343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correspondency between different affinity states and target size of the bovine striatal D2 dopamine receptor.
    Kuno T; Tanaka C
    Biochem Biophys Res Commun; 1983 Nov; 117(1):65-70. PubMed ID: 6197972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
    J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
    Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
    J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist.
    Neumeyer JL; Gao YG; Kula NS; Baldessarini RJ
    J Med Chem; 1990 Dec; 33(12):3122-4. PubMed ID: 2147956
    [No Abstract]   [Full Text] [Related]  

  • 8. R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist.
    Baldessarini RJ; Kula NS; Gao Y; Campbell A; Neumeyer JL
    Neuropharmacology; 1991 Jan; 30(1):97-9. PubMed ID: 1675452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuously infusing quinpirole decreases Ca2+/calmodulin-dependent phosphorylation in mouse striatum.
    Zhang SP; Zhou LW; Natsukari N; Weiss B
    Neurochem Int; 1993 Oct; 23(4):361-72. PubMed ID: 8220178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors.
    Rogue P; Zwiller J; Malviya AN; Vincendon G
    Biochem Int; 1990 Nov; 22(3):575-82. PubMed ID: 1981673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of two pertussis toxin-sensitive G-proteins with the D2-dopamine receptor from bovine striatum.
    Elazar Z; Siegel G; Fuchs S
    EMBO J; 1989 Aug; 8(8):2353-7. PubMed ID: 2571500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
    J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
    Munemura M; Agui T; Sibley DR
    Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
    Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS; Runice C; Dowd F
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective decrease in the affinity of D2 dopamine receptor for agonist induced by islet-activating protein, pertussis toxin, associated with ADP-ribosylation of the specific membrane protein of bovine striatum.
    Kuno T; Shirakawa O; Tanaka C
    Biochem Biophys Res Commun; 1983 Aug; 115(1):325-30. PubMed ID: 6225433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S
    J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.